Slovakia -
Slovak -
Ústav štátnej kontroly veterinárnych biopreparátov a liečiv
fatroseal 2,6 g intramamálna suspenzia pre hovädzí dobytok počas státia nasucho
fatro s.p.a., taliansko - susp.
Slovakia -
Slovak -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
anastrozol sandoz 1 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - anastrozol - 44 - cytostatica
Slovakia -
Slovak -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
anastrozol-ratiopharm 1 mg
ratiopharm gmbh, nemecko - anastrozol - 44 - cytostatica
Slovakia -
Slovak -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
anastrozol ebewe 1 mg
sandoz pharmaceuticals d.d., slovinsko - anastrozol - 44 - cytostatica
Uni Eropa -
Slovak -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
Uni Eropa -
Slovak -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.